Samsung Life, Hanwha Life, Kyobo Life join KDB Life acquisition race alongside Korea Investment, Taekwang

All three of South Korea's largest life insurers — Samsung Life, Hanwha Life and Kyobo Life — have entered the race to acquire KDB Life Insurance, defying earlier expectations and injecting fresh momentum into a sale process that has dragged on for 12 years. The surprise turnout has drawn market attention to whether a deal can finally be sealed, though some analysts caution that a genuinely competitive bidding war has yet to take shape.

PricewaterhouseCoopers Samil, the sale adviser for KDB Life, received letters of intent by 3 p.m. Monday, with five or more prospective buyers submitting bids in the preliminary round. Confirmed participants include Korea Investment Holdings, Heungkuk Life Insurance — an affiliate of Taekwang Group — Samsung Life, Hanwha Life and Kyobo Life. The industry had initially anticipated a two-way contest between Korea Investment Holdings and Heungkuk Life, but the entry of all three major insurers has significantly broadened the field.

Industry watchers attribute the stronger-than-expected interest largely to the possibility that Korea Development Bank will inject fresh capital into KDB Life before completing the sale. KDB has signaled it intends to pursue a more flexible deal structure than in previous attempts to improve the chances of closing a transaction, and a large-scale rights offering could reduce the financial burden on any acquirer. KDB conducted a 500 billion won (approximately $333 million) rights offering in KDB Life at the end of last year, lifting its stake to 99.66 percent, and is reportedly planning an additional capital injection of hundreds of billions of won this year. Estimates suggest the new offering could range from 300 billion won to 500 billion won.

Questions remain, however, over whether the three major insurers are entering the preliminary round with genuine competitive intent. "All parties are citing confidentiality agreements and are not disclosing specific terms or the details of their reviews beyond confirming participation," one insurance industry official said. "At this point it is hard to characterize the situation as an overheated competition — my understanding is that substantive interest is concentrated on Korea Investment Holdings and Heungkuk Life."

KDB plans to conduct a preliminary review and evaluate the letters of intent before announcing a shortlist of qualified acquisition candidates. The bank then aims to proceed to a main auction in August following due diligence, select a preferred negotiating partner during the third quarter and close the transaction before year-end.

The sale of KDB Life has been attempted six times since 2014, with every effort falling through due to concerns over the insurer's financial soundness and the failure to obtain regulatory approval for prospective controlling shareholders. KDB has poured a total of 2.1 trillion won into stabilizing KDB Life over that period.